rs3887873

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBA1

The NM_007171.4(POMT1):​c.751C>T​(p.Gln251*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,613,992 control chromosomes in the GnomAD database, including 12,650 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.12 ( 1165 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11485 hom. )

Consequence

POMT1
NM_007171.4 stop_gained

Scores

1
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.0490
Variant links:
Genes affected
POMT1 (HGNC:9202): (protein O-mannosyltransferase 1) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT2 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS) and limb-girdle muscular dystrophy type 2K (LGMD2K). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 9-131510048-C-T is Benign according to our data. Variant chr9-131510048-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 95466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-131510048-C-T is described in Lovd as [Likely_benign]. Variant chr9-131510048-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POMT1NM_001077365.2 linkc.699+52C>T intron_variant Intron 8 of 19 ENST00000402686.8 NP_001070833.1 Q9Y6A1-2A0A140VKE0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POMT1ENST00000402686.8 linkc.699+52C>T intron_variant Intron 8 of 19 1 NM_001077365.2 ENSP00000385797.4 Q9Y6A1-2

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17877
AN:
152074
Hom.:
1165
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.119
Gnomad AMR
AF:
0.100
Gnomad ASJ
AF:
0.111
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0478
Gnomad FIN
AF:
0.150
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.115
GnomAD3 exomes
AF:
0.102
AC:
25489
AN:
251118
Hom.:
1602
AF XY:
0.100
AC XY:
13619
AN XY:
135714
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.0612
Gnomad ASJ exome
AF:
0.115
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.0493
Gnomad FIN exome
AF:
0.154
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.120
AC:
175970
AN:
1461800
Hom.:
11485
Cov.:
33
AF XY:
0.118
AC XY:
85891
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.108
Gnomad4 AMR exome
AF:
0.0643
Gnomad4 ASJ exome
AF:
0.117
Gnomad4 EAS exome
AF:
0.000353
Gnomad4 SAS exome
AF:
0.0530
Gnomad4 FIN exome
AF:
0.156
Gnomad4 NFE exome
AF:
0.132
Gnomad4 OTH exome
AF:
0.111
GnomAD4 genome
AF:
0.118
AC:
17887
AN:
152192
Hom.:
1165
Cov.:
33
AF XY:
0.118
AC XY:
8797
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.114
Gnomad4 AMR
AF:
0.100
Gnomad4 ASJ
AF:
0.111
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.0480
Gnomad4 FIN
AF:
0.150
Gnomad4 NFE
AF:
0.133
Gnomad4 OTH
AF:
0.114
Alfa
AF:
0.119
Hom.:
2223
Bravo
AF:
0.110
TwinsUK
AF:
0.131
AC:
487
ALSPAC
AF:
0.131
AC:
503
ESP6500AA
AF:
0.0897
AC:
395
ESP6500EA
AF:
0.101
AC:
871
ExAC
AF:
0.103
AC:
12565
Asia WGS
AF:
0.0290
AC:
102
AN:
3478
EpiCase
AF:
0.124
EpiControl
AF:
0.122

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 28, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Gln251Trp in exon 8 of POMT1: This variant is not expected to have clinical si gnificance because it has been identified in at least 8.8% (10687/121366) of chr omosomes from multiple diverse populations by the Exome Aggregation Consortium ( ExAC, http://exac.broadinstitute.org). -

Jul 24, 2012
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 19, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: POMT1 c.751C>T (p.Gln251X) results in a premature termination codon. The variant allele was found at a frequency of 0.1 in 251118 control chromosomes in the gnomAD database, including 1602 homozygotes. The observed variant frequency is approximately 140.65 fold of the estimated maximal expected allele frequency for a pathogenic variant in POMT1 causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.00072), strongly suggesting that the variant is benign. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -

Dec 19, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
-
Clinical Genetics, Academic Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 14, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Autosomal recessive limb-girdle muscular dystrophy type 2K Benign:2
Oct 25, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
0.020
CADD
Benign
0.43
DANN
Benign
0.84
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.011
N
Vest4
0.34
GERP RS
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3887873; hg19: chr9-134385435; COSMIC: COSV61225923; COSMIC: COSV61225923; API